Methapharm is a specialty pharmaceutical company with a focus on the acquisition, licensing, partnering, and promotion of specialty pharmaceutical products in North America. We market our own proprietary products and partner with global companies to deliver a comprehensive line of prescription drug products in the USA and/or Canada. In addition to our North American activities, Methapharm is seeking to expand its international network for its portfolio of diagnostic products. Our focus is on hospital products as well as specialties in the areas of respiratory, imaging, oncology, and neonatology.
Methapharm is a privately held, specialty pharmaceutical company that began operating in 1996 as a spin-off from the ACIC group of companies. Operating since 1976, the ACIC Group has divisions active in the fields of active pharmaceutical ingredient manufacturing, generic drug development, and pharmaceutical manufacturing equipment automation and systems integration.
Originally conceived to develop branded products from APIs manufactured within the ACIC Group, Methapharm now also partners with a number of leading international pharmaceutical companies to market and distribute their products in North America. Today, Methapharm is licensed to distribute prescription drugs in all U.S. states and Canada and we operate distribution facilities in both countries. Our comprehensive capabilities make us an ideal partner for specialty products.
We help bring needed products to practitioners and patients. Our mission is to enhance patient care by making specialty products available to address unmet medical needs or improve quality of life.